M.‐C. Woronoff‐Lemsi

453 total citations
26 papers, 335 citations indexed

About

M.‐C. Woronoff‐Lemsi is a scholar working on Economics and Econometrics, General Health Professions and Hematology. According to data from OpenAlex, M.‐C. Woronoff‐Lemsi has authored 26 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 4 papers in General Health Professions and 4 papers in Hematology. Recurrent topics in M.‐C. Woronoff‐Lemsi's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Health, Medicine and Society (4 papers) and Acute Myeloid Leukemia Research (3 papers). M.‐C. Woronoff‐Lemsi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Health, Medicine and Society (4 papers) and Acute Myeloid Leukemia Research (3 papers). M.‐C. Woronoff‐Lemsi collaborates with scholars based in France and United States. M.‐C. Woronoff‐Lemsi's co-authors include Samuel Limat, Éric Deconinck, A. Brion, Jean‐Yves Cahn, Laurent Voillat, Yvette Bernard, Virginie Nerich, Christophe Borg, Étienne Daguindau and J.L. Dupond and has published in prestigious journals such as Cancer, Annals of Oncology and British Journal of Clinical Pharmacology.

In The Last Decade

M.‐C. Woronoff‐Lemsi

24 papers receiving 321 citations

Peers

M.‐C. Woronoff‐Lemsi

CCM

ONCOL

PFM

PRM

Scott Smith United States

David J. Rosenberg United States

Marc A G J ten Dam Netherlands

D Mouton-Schleifer France

A. Scott Mathis United States

Anne Chiffoleau France

Antonia Harford United States

Yueh‐Han Hsu Taiwan

Eike Wrenger Germany

Welch United States

Scott Smith United States

M.‐C. Woronoff‐Lemsi

47 ×0.4

CCM

41 ×0.6

ONCOL

31 ×0.5

PFM

21 ×0.4

55 ×1.3

PRM

Citations per year, relative to M.‐C. Woronoff‐Lemsi M.‐C. Woronoff‐Lemsi (= 1×) peers Scott Smith

Countries citing papers authored by M.‐C. Woronoff‐Lemsi

Since Specialization

Citations

This map shows the geographic impact of M.‐C. Woronoff‐Lemsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.‐C. Woronoff‐Lemsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.‐C. Woronoff‐Lemsi more than expected).

Fields of papers citing papers by M.‐C. Woronoff‐Lemsi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.‐C. Woronoff‐Lemsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.‐C. Woronoff‐Lemsi. The network helps show where M.‐C. Woronoff‐Lemsi may publish in the future.

Co-authorship network of co-authors of M.‐C. Woronoff‐Lemsi

This figure shows the co-authorship network connecting the top 25 collaborators of M.‐C. Woronoff‐Lemsi. A scholar is included among the top collaborators of M.‐C. Woronoff‐Lemsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.‐C. Woronoff‐Lemsi. M.‐C. Woronoff‐Lemsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nerich, Virginie, Christophe Guyeux, M. Henry‐Amar, et al.. (2021). Economic burden in non‐Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross‐sectional study. Cancer. 128(3). 519–528. 1 indexed citations

Belhassen, Manon, Florence Tubach, Christophe Hudry, et al.. (2020). Impact of persistence with tumour necrosis factor inhibitors on healthcare resource utilization and costs in chronic inflammatory joint diseases. British Journal of Clinical Pharmacology. 87(1). 163–177. 5 indexed citations

Limat, Samuel, Étienne Daguindau, J Cahn, et al.. (2014). Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma. Journal of Clinical Pharmacy and Therapeutics. 39(2). 168–174. 41 indexed citations

Nerich, Virginie, Samuel Limat, Martin Demarchi, et al.. (2010). Computerized physician order entry of injectable antineoplastic drugs: An epidemiologic study of prescribing medication errors. International Journal of Medical Informatics. 79(10). 699–706. 54 indexed citations

Martin, Myriam, et al.. (2009). Schizophrenia: cost of illness. 27(7). 421–433. 1 indexed citations

Guillaume, Yves Claude, et al.. (2008). Magnesium effect on testosterone–SHBG association studied by a novel molecular chromatography approach. Journal of Pharmaceutical and Biomedical Analysis. 49(2). 175–180. 9 indexed citations

Grenouillet, Frédéric, Faézeh Legrand, M.‐C. Woronoff‐Lemsi, et al.. (2008). Audit clinique des prescriptions d’antifongiques systémiques couteux au centre hospitalier universitaire de Besançon. Médecine et Maladies Infectieuses. 39(2). 125–132. 10 indexed citations

Fagnoni, Philippe, Virginie Nerich, Samuel Limat, et al.. (2008). Hospital Costs of Renal Transplant Management. Transplantation Proceedings. 40(10). 3440–3444. 5 indexed citations

Woronoff‐Lemsi, M.‐C., et al.. (2005). Étude comparative rétrospective de l'impact médicoéconomique d'un renfort innovant dans la cure des éventrations de la paroi abdominale antérieure. Annales de Chirurgie. 130(8). 466–469. 2 indexed citations

10.

Legat, Christoph, et al.. (2003). Economic impact of centralized preparation of cytotoxic drugs. Journal de Pharmacie Clinique. 22(4). 181–185. 1 indexed citations

11.

Limat, Samuel, et al.. (2003). Impact économique de la préparation centralisée des médicaments anticancéreux. Journal de Pharmacie Clinique. 22(4). 181–185. 11 indexed citations

12.

Limat, Samuel, Laurent Voillat, Yvette Bernard, et al.. (2003). Early cardiotoxicity of the CHOP regimen in aggressivenon-Hodgkin’s lymphoma. Annals of Oncology. 14(2). 277–281. 110 indexed citations

13.

Fagnoni, Philippe, et al.. (2002). Malaise hypotensif d'origine iatrogène chez une patiente inobservante. Journal de Pharmacie Clinique. 21(3). 211–214.

14.

Talon, D., M.‐C. Woronoff‐Lemsi, Samuel Limat, et al.. (2002). The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. European Journal of Internal Medicine. 13(1). 31–36. 37 indexed citations

15.

Woronoff‐Lemsi, M.‐C., et al.. (2001). [Cost effectiveness of GM-CSF in the treatment of acute myeloblastic leukemia in aged patients: protocol of GOELAM Sa3].. PubMed. 56(2). 131–3. 5 indexed citations

16.

Tissot, E, et al.. (2000). Déficits acquis en fibrinogène et en antithrombine III au cours des traitements des leucémies aiguës lymphoblastiques de l’enfant. Journal de Pharmacie Clinique. 19(2). 115–117. 1 indexed citations

17.

Woronoff‐Lemsi, M.‐C., et al.. (2000). Cost analysis of allogeneic bone marrow transplantation. 42(2-3). 149–154. 3 indexed citations

18.

Woronoff‐Lemsi, M.‐C., et al.. (1999). Erythropoietin and preoperative autologous blood donation in the prevention of hepatitis C infection:necessity or luxury?. Transfusion. 39(9). 933–937. 11 indexed citations

19.

Cahn, Jean‐Yves, Éric Deconinck, Pierre Tiberghien, et al.. (1999). Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantation. PubMed. 41(2). 31–37. 2 indexed citations

20.

Woronoff‐Lemsi, M.‐C., et al.. (1997). Evaluation du service pharmaceutique rendu dans le déroulement et la gestion des essais cliniques. Journal de Pharmacie Clinique. 16(3). 199–203. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact